ID   CDK3_HUMAN              Reviewed;         305 AA.
AC   Q00526;
DT   01-APR-1993, integrated into UniProtKB/Swiss-Prot.
DT   01-APR-1993, sequence version 1.
DT   15-MAR-2017, entry version 177.
DE   RecName: Full=Cyclin-dependent kinase 3;
DE            EC=2.7.11.22;
DE   AltName: Full=Cell division protein kinase 3;
GN   Name=CDK3; Synonyms=CDKN3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Fetal brain;
RX   PubMed=1639063;
RA   Meyerson M., Enders G.H., Wu C.-L., Su L.-K., Gorka C., Nelson C.,
RA   Harlow E., Tsai L.-H.;
RT   "A family of human cdc2-related protein kinases.";
RL   EMBO J. 11:2909-2917(1992).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS ILE-226 AND THR-264.
RG   NIEHS SNPs program;
RL   Submitted (OCT-2004) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   FUNCTION IN G1-S TRANSITION.
RX   PubMed=8846921; DOI=10.1101/gad.10.7.851;
RA   Hofmann F., Livingston D.M.;
RT   "Differential effects of cdk2 and cdk3 on the control of pRb and E2F
RT   function during G1 exit.";
RL   Genes Dev. 10:851-861(1996).
RN   [4]
RP   FUNCTION AS RB1 KINASE, FUNCTION IN G0-G1 TRANSITION, AND INTERACTION
RP   WITH CCNC.
RX   PubMed=15084261; DOI=10.1016/S0092-8674(04)00300-9;
RA   Ren S., Rollins B.J.;
RT   "Cyclin C/cdk3 promotes Rb-dependent G0 exit.";
RL   Cell 117:239-251(2004).
RN   [5]
RP   FUNCTION AS ATF1 KINASE, TISSUE SPECIFICITY, AND INTERACTION WITH
RP   ATF1.
RX   PubMed=18794154; DOI=10.1158/0008-5472.CAN-08-1137;
RA   Zheng D., Cho Y.-Y., Lau A.T.Y., Zhang J., Ma W.-Y., Bode A.M.,
RA   Dong Z.;
RT   "Cyclin-dependent kinase 3-mediated activating transcription factor 1
RT   phosphorylation enhances cell transformation.";
RL   Cancer Res. 68:7650-7660(2008).
RN   [6]
RP   VARIANTS [LARGE SCALE ANALYSIS] ASN-106; THR-124; HIS-214 AND THR-264.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Serine/threonine-protein kinase that plays a critical
CC       role in the control of the eukaryotic cell cycle; involved in G0-
CC       G1 and G1-S cell cycle transitions. Interacts with CCNC/cyclin-C
CC       during interphase. Phosphorylates histone H1, ATF1, RB1 and
CC       CABLES1. ATF1 phosphorylation triggers ATF1 transactivation and
CC       transcriptional activities, and promotes cell proliferation and
CC       transformation. CDK3/cyclin-C mediated RB1 phosphorylation is
CC       required for G0-G1 transition. Promotes G1-S transition probably
CC       by contributing to the activation of E2F1, E2F2 and E2F3 in a RB1-
CC       independent manner. {ECO:0000269|PubMed:15084261,
CC       ECO:0000269|PubMed:18794154, ECO:0000269|PubMed:8846921}.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- SUBUNIT: Interacts with CABLES1 and CABLES2 (By similarity).
CC       Interacts with ATF1. Binding to CCNC/cyclin-C promotes RB1
CC       phosphorylation. {ECO:0000250, ECO:0000269|PubMed:15084261,
CC       ECO:0000269|PubMed:18794154}.
CC   -!- INTERACTION:
CC       P38936:CDKN1A; NbExp=4; IntAct=EBI-1245761, EBI-375077;
CC       P61024:CKS1B; NbExp=3; IntAct=EBI-1245761, EBI-456371;
CC   -!- TISSUE SPECIFICITY: Expressed in cancer cell lines and
CC       glioblastoma tissue. {ECO:0000269|PubMed:18794154}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. CMGC
CC       Ser/Thr protein kinase family. CDC2/CDKX subfamily. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=NIEHS-SNPs;
CC       URL="http://egp.gs.washington.edu/data/cdk3/";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X66357; CAA47001.1; -; mRNA.
DR   EMBL; AY789470; AAV40830.1; -; Genomic_DNA.
DR   CCDS; CCDS11736.1; -.
DR   PIR; S23382; S23382.
DR   RefSeq; NP_001249.1; NM_001258.2.
DR   UniGene; Hs.706766; -.
DR   PDB; 1LFN; Model; -; A=1-305.
DR   PDBsum; 1LFN; -.
DR   ProteinModelPortal; Q00526; -.
DR   SMR; Q00526; -.
DR   BioGrid; 107453; 47.
DR   DIP; DIP-686N; -.
DR   IntAct; Q00526; 41.
DR   MINT; MINT-1509509; -.
DR   STRING; 9606.ENSP00000400088; -.
DR   BindingDB; Q00526; -.
DR   ChEMBL; CHEMBL4442; -.
DR   GuidetoPHARMACOLOGY; 1975; -.
DR   iPTMnet; Q00526; -.
DR   PhosphoSitePlus; Q00526; -.
DR   BioMuta; CDK3; -.
DR   DMDM; 231726; -.
DR   EPD; Q00526; -.
DR   MaxQB; Q00526; -.
DR   PaxDb; Q00526; -.
DR   PeptideAtlas; Q00526; -.
DR   PRIDE; Q00526; -.
DR   DNASU; 1018; -.
DR   Ensembl; ENST00000425876; ENSP00000410561; ENSG00000250506.
DR   GeneID; 1018; -.
DR   KEGG; hsa:1018; -.
DR   UCSC; uc010dgt.3; human.
DR   CTD; 1018; -.
DR   DisGeNET; 1018; -.
DR   GeneCards; CDK3; -.
DR   HGNC; HGNC:1772; CDK3.
DR   HPA; HPA007420; -.
DR   MIM; 123828; gene.
DR   neXtProt; NX_Q00526; -.
DR   OpenTargets; ENSG00000250506; -.
DR   PharmGKB; PA26309; -.
DR   eggNOG; KOG0594; Eukaryota.
DR   eggNOG; ENOG410XPP3; LUCA.
DR   GeneTree; ENSGT00830000128256; -.
DR   HOGENOM; HOG000233024; -.
DR   HOVERGEN; HBG014652; -.
DR   InParanoid; Q00526; -.
DR   KO; K02088; -.
DR   OMA; DAVGFCH; -.
DR   OrthoDB; EOG091G0CH0; -.
DR   PhylomeDB; Q00526; -.
DR   TreeFam; TF101021; -.
DR   BRENDA; 2.7.11.22; 2681.
DR   SignaLink; Q00526; -.
DR   SIGNOR; Q00526; -.
DR   GeneWiki; Cyclin-dependent_kinase_3; -.
DR   GenomeRNAi; 1018; -.
DR   PRO; PR:Q00526; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   Bgee; ENSG00000250506; -.
DR   CleanEx; HS_CDK3; -.
DR   ExpressionAtlas; Q00526; baseline and differential.
DR   Genevisible; Q00526; HS.
DR   GO; GO:0000307; C:cyclin-dependent protein kinase holoenzyme complex; IBA:GO_Central.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0030332; F:cyclin binding; IBA:GO_Central.
DR   GO; GO:0004693; F:cyclin-dependent protein serine/threonine kinase activity; IBA:GO_Central.
DR   GO; GO:0051301; P:cell division; IEA:UniProtKB-KW.
DR   GO; GO:0008283; P:cell proliferation; TAS:UniProtKB.
DR   GO; GO:0006974; P:cellular response to DNA damage stimulus; IDA:MGI.
DR   GO; GO:0045023; P:G0 to G1 transition; TAS:UniProtKB.
DR   GO; GO:0000082; P:G1/S transition of mitotic cell cycle; TAS:UniProtKB.
DR   GO; GO:0007067; P:mitotic nuclear division; IEA:UniProtKB-KW.
DR   GO; GO:0007275; P:multicellular organism development; IBA:GO_Central.
DR   GO; GO:0008284; P:positive regulation of cell proliferation; IBA:GO_Central.
DR   GO; GO:0006468; P:protein phosphorylation; IBA:GO_Central.
DR   GO; GO:0010389; P:regulation of G2/M transition of mitotic cell cycle; IBA:GO_Central.
DR   GO; GO:0010468; P:regulation of gene expression; IBA:GO_Central.
DR   GO; GO:0010033; P:response to organic substance; IBA:GO_Central.
DR   GO; GO:0007165; P:signal transduction; IBA:GO_Central.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   3D-structure; ATP-binding; Cell cycle; Cell division;
KW   Complete proteome; Kinase; Mitosis; Nucleotide-binding; Polymorphism;
KW   Reference proteome; Serine/threonine-protein kinase; Transferase.
FT   CHAIN         1    305       Cyclin-dependent kinase 3.
FT                                /FTId=PRO_0000085776.
FT   DOMAIN        4    286       Protein kinase. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   NP_BIND      10     18       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   ACT_SITE    127    127       Proton acceptor. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159, ECO:0000255|PROSITE-
FT                                ProRule:PRU10027}.
FT   BINDING      33     33       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   VARIANT     106    106       S -> N (in a glioblastoma multiforme
FT                                sample; somatic mutation).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041973.
FT   VARIANT     124    124       I -> T (in dbSNP:rs34918446).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041974.
FT   VARIANT     214    214       R -> H (in dbSNP:rs34670267).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041975.
FT   VARIANT     226    226       T -> I (in dbSNP:rs2069532).
FT                                {ECO:0000269|Ref.2}.
FT                                /FTId=VAR_021101.
FT   VARIANT     264    264       M -> T (in dbSNP:rs17884251).
FT                                {ECO:0000269|PubMed:17344846,
FT                                ECO:0000269|Ref.2}.
FT                                /FTId=VAR_021102.
SQ   SEQUENCE   305 AA;  35046 MW;  1128BE0096EA262A CRC64;
     MDMFQKVEKI GEGTYGVVYK AKNRETGQLV ALKKIRLDLE MEGVPSTAIR EISLLKELKH
     PNIVRLLDVV HNERKLYLVF EFLSQDLKKY MDSTPGSELP LHLIKSYLFQ LLQGVSFCHS
     HRVIHRDLKP QNLLINELGA IKLADFGLAR AFGVPLRTYT HEVVTLWYRA PEILLGSKFY
     TTAVDIWSIG CIFAEMVTRK ALFPGDSEID QLFRIFRMLG TPSEDTWPGV TQLPDYKGSF
     PKWTRKGLEE IVPNLEPEGR DLLMQLLQYD PSQRITAKTA LAHPYFSSPE PSPAARQYVL
     QRFRH
//
